Corrado Pelaia
Magna Graecia University(IT)Azienda Ospedaliero Universitario Mater Domini(IT)
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Allergic Rhinitis and Sensitization, Eosinophilic Esophagitis, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → Interleukin-5 in the Pathophysiology of Severe Asthma(2019)311 cited
- → Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness(2018)147 cited
- → Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets(2022)146 cited
- → Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma(2018)140 cited
- → Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications(2020)137 cited
- → Molecular Targets for Biological Therapies of Severe Asthma(2020)128 cited
- → Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab(2017)99 cited
- → Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study(2021)80 cited
- → Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis(2018)77 cited
- → Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype(2020)77 cited